By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288



Company News
ASCO15: NanoString (NSTG) Highlights Results From Three Significant New Prosigna Studies Presented At The 51st Annual Meeting Of The ASCO 6/1/2015 3:11:26 PM
Merck & Co. (MRK) And NanoString (NSTG) Announce Clinical Research Collaboration To Develop An Immune-Related Gene Expression Assay For Use In The Development Program For KEYTRUDA (Pembrolizumab) 5/28/2015 9:43:15 AM
Four Seattle Biotech Firms Looking to Hire Hundreds of New Employees 5/21/2015 6:31:28 AM
NanoString (NSTG) Announces Favorable Draft Local Coverage Determination By Palmetto GBA For Its Prosigna Breast Cancer Assay 5/15/2015 7:20:23 AM
NanoString (NSTG) Release: St. Gallen International Breast Cancer Guidelines Recognize Power Of Prosigna/PAM50 To Inform Treatment Decisions And Spare Low Risk Breast Cancer Patients Unnecessary Chemotherapy 5/12/2015 7:44:44 AM
NanoString (NSTG) To Present At The UBS Global Healthcare Conference 5/7/2015 12:12:31 PM
NanoString (NSTG) Releases Financial Results For First Quarter Of 2015 5/7/2015 8:26:24 AM
NanoString (NSTG) Reports 35 Percent Loss, Remains Positive, Ramps Up Hiring 5/7/2015 6:23:08 AM
NanoString (NSTG) And Cancer Immunotherapy Trials Network (CITN) Enter Into A Collaboration To Identify Biomarker Assays For Novel Cancer Immunotherapies 5/6/2015 7:22:43 AM
NanoString (NSTG) To Release First Quarter 2015 Financial Results And Host Conference Call On Wednesday, May 6, 2015 4/23/2015 10:34:38 AM